Genpact Insider Sale: Anil Nanduru Disposes 27,962 Shares at $44.50–$45.50

Rhea-AI Filing Summary

Anil Nanduru, Senior Vice President at Genpact Limited (G), reported two open-market sales of company common shares on Aug 21–22, 2025. He sold 18,218 shares on 08/21/2025 at $44.50 per share and 9,744 shares on 08/22/2025 at $45.50 per share, reducing his beneficial ownership to 89,846 common shares after the transactions. The filing notes that his total holdings include 237 shares received via dividend reinvestment since his prior Form 4. The Form 4 is signed by an attorney-in-fact for the reporting person.

Positive

• None.

Negative

• Insider sold a total of 27,962 shares (18,218 on 08/21/2025 at $44.50 and 9,744 on 08/22/2025 at $45.50), reducing holdings to 89,846 shares
• Form 4 does not state a 10b5-1 trading plan or other execution plan in the filing, providing limited context for the sales

Insights

Financial Analyst

TL;DR: Insider sold 27,962 shares across two days; holdings remain material but this is a routine disclosure without further context.

The filing shows two open-market dispositions totaling 27,962 shares at weighted average prices near $45. These sales reduced the reporting person's beneficial ownership to 89,846 shares. Without accompanying information on timing, planned sale program, or proportion of total outstanding shares, the transactions are a straightforward Section 16 disclosure. For investors, the data documents liquidity activity by a senior officer but does not alone indicate change in company fundamentals.

Corporate Governance Expert

TL;DR: The Form 4 properly discloses officer sales and notes dividend reinvestment; no governance red flags evident from this filing alone.

The report identifies the reporting person as a Senior Vice President and indicates two sale transactions executed on consecutive days. The form includes an explanatory note that 237 shares were added via dividend reinvestment since the prior filing and is signed by an attorney-in-fact. There is no indication in this filing of trading under a Rule 10b5-1 plan or any amendment; governance implications are limited without additional contextual filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Nanduru Anil

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NY 10175

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Senior Vice President

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/21/2025		S		18,218	D	$44.5	99,590(1)	D
Common Shares	08/22/2025		S		9,744	D	$45.5	89,846(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 237 shares acquired through dividend reinvestment since the reporting person's Form 4 filed on March 13, 2025.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Anil Nanduru	08/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Genpact Limited (G)?

The Form 4 was filed for Anil Nanduru, who is identified as a Senior Vice President of Genpact Limited.

How many Genpact (G) shares did the insider sell and at what prices?

The filing reports sales of 18,218 shares on 08/21/2025 at $44.50 and 9,744 shares on 08/22/2025 at $45.50.

What is the insider's beneficial ownership after the reported transactions?

Following the reported transactions, the insider beneficially owns 89,846 common shares.

Does the Form 4 mention dividend reinvestment or other adjustments?

Yes. The filing explains that 237 shares were acquired through dividend reinvestment since the reporting person's prior Form 4.

Was the Form 4 signed by the reporting person?

The signature block shows the form was signed by Thomas D. Scholtes, as Attorney-in-fact for Anil Nanduru on 08/25/2025.